Cite
HARVARD Citation
Sandborn, W. et al. (2004). CDP571, a humanised monoclonal antibody to tumour necrosis factor α, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trial. Gut. 53 (10), pp. 1485-1493. [Online].